Priority Date: 15.06.11 (US 201161497123P)

DOUBLE-ACYLATED GLP-1 DERIVATIVES

  • Application ID: EP11779456
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Novo Nordisk A/S is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 221 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 15.06.2011 - Priority Date (US 201161497123P)
  • 18.05.2012 - Publication A1 (WO2012062803)
  • 18.09.2013 - Publication A1 (EP2637698)

IPC Classification